Recurrent Non-small Cell Lung Cancer Recruiting Phase 1 Trials for Docetaxel (DB01248)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02889666A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung CancerTreatment